Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma

NCT03662776 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT03662776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03662776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 31, 2018
Completion date
August 31, 2027
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

survivors of unilateral retinoblastoma